Clin Med Insights Endocrinol Diabetes. 2026 May 6;19:11795514261441435. doi: 10.1177/11795514261441435. eCollection 2026.
ABSTRACT
Variants in the Glucokinase Regulator (GCKR) gene are increasingly being detected with growing applications of genomic sequencing technologies. Despite the crucial roles of the GCKR gene in energy homeostasis, the clinical applications of GCKR variants are currently limited. We observed that a large proportion of GCKR variants that are available in gnomAD database (https://gnomad.broadinstitute.org/) lacked adequate evidence of pathogenicity or benign impact. We highlight the clinical need for an improved understanding of GCKR variants by presenting 2 compelling cases of unrelated families (3 individuals in total) who harbor rare GCKR variants in the context of cornea arcus and hyperlipidemia. Our observations underscore the burgeoning need for functional as well as family segregation studies to facilitate the clinical applications of GCKR variants.
PMID:42131858 | PMC:PMC13161669 | DOI:10.1177/11795514261441435